Seoul, South Korea

Taegon Baik

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 4.3

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2019-2024

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Taegon Baik in Eye Disease Treatment

Introduction

Taegon Baik is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of eye diseases. With a total of 3 patents to his name, Baik's work focuses on innovative peptide compositions that enhance tear secretion and promote corneal repair.

Latest Patents

Baik's latest patents include a peptide and pharmaceutical composition for treating eye diseases. This invention relates to peptides and pharmaceutical compositions that serve as active ingredients for treating various eye conditions. The administration of these peptides can increase tear secretion and aid in the repair of corneal damage. Additionally, he has developed novel peptides and pharmaceutical compositions that are effective therapeutic agents for eye diseases. These compounds, when administered to the eyes, not only increase tear secretion but also facilitate the recovery of damaged corneas.

Career Highlights

Taegon Baik is currently associated with Yuyu Pharma, Inc., where he continues to innovate in the pharmaceutical sector. His work has garnered attention for its potential to improve the quality of life for individuals suffering from eye diseases.

Collaborations

Baik collaborates with esteemed colleagues such as Jong-Yun Choi and Gyoung-Wook Min, contributing to a dynamic research environment focused on advancing therapeutic solutions.

Conclusion

Taegon Baik's innovative work in the field of eye disease treatment showcases the potential of peptide-based therapies. His contributions are paving the way for new therapeutic options that can significantly benefit patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…